[225Ac]Ac-PSMA-617 augmented [177Lu]Lu-PSMA-617 RLT in challenging advanced mCRPC patients

被引：0
|
作者：
Rosar, F. [1 ]
Krause, J. [1 ]
Bartholomae, M. [1 ]
Maus, S. [1 ]
Stemler, T. [1 ]
Hierlmeier, I. [1 ]
Linxweiler, J. [2 ]
Ezziddin, S. [1 ]
Khreish, F. [1 ]
机构：
[1] Saarland Univ, Dept Nucl Med, Med Ctr, Homburg, Germany
[2] Saarland Univ, Dept Urol, Med Ctr, Homburg, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-0901
引用
收藏
页码：S315 / S315
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of [225Ac]Ac-PSMA-617 Augmented [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Highly Advanced mCRPC with Poor Prognosis
    Rosar, Florian
    Krause, Jonas
    Bartholoma, Mark
    Maus, Stephan
    Stemler, Tobias
    Hierlmeier, Ina
    Linxweiler, Johannes
    Ezziddin, Samer
    Khreish, Fadi
    [J]. PHARMACEUTICS, 2021, 13 (05)
  • [2] Molecular imaging and biochemical response assessment after a single cycle of [225Ac]Ac-PSMA-617/[177Lu]Lu-PSMA-617 tandem therapy in mCRPC patients who have progressed on [177Lu]Lu-PSMA-617 monotherapy
    Rosar, Florian
    Hau, Fabian
    Bartholoma, Mark
    Maus, Stephan
    Stemler, Tobias
    Linxweiler, Johannes
    Ezziddin, Samer
    Khreish, Fadi
    [J]. THERANOSTICS, 2021, 11 (09): : 4050 - 4060
  • [3] AcTION: A phase 1 study of [225Ac]Ac-PSMA-617 in men with PSMA-positive prostate cancer with or without prior [177Lu]Lu-PSMA-617 radioligand therapy
    Sathekge, M.
    Crumbaker, M.
    Joshua, A. M.
    Bruchertseifer, F.
    Kreisl, T.
    Emineni, S.
    Wehbe, J.
    Korn, M.
    Morgenstern, A.
    Emmett, L.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S152 - S153
  • [4] Deescalated 225 Ac-PSMA-617 Versus 177 Lu/ 225 Ac-PSMA-617 Cocktail Therapy: A Single-Center Retrospective Analysis of 233 Patients
    Rathke, Hendrik
    Winter, Erik
    Bruchertseifer, Frank
    Roehrich, Manuel
    Giesel, Frederik Lars
    Haberkorn, Uwe
    Morgenstern, Alfred
    Kratochwil, Clemens
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (07) : 1057 - 1063
  • [5] Urinary excretion kinetics of [177Lu]Lu-PSMA-617
    de Bakker, Maarten
    Dominicus, Noa
    Meeuwis, Antoi
    Janssen, Marcel
    Konijnenberg, Mark W. W.
    Nagarajah, James
    Peters, Steffie M. B.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (12) : 3572 - 3575
  • [6] Urinary excretion kinetics of [177Lu]Lu-PSMA-617
    Maarten de Bakker
    Noa Dominicus
    Antoi Meeuwis
    Marcel Janssen
    Mark W. Konijnenberg
    James Nagarajah
    Steffie M. B. Peters
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3572 - 3575
  • [7] Dose-dependent relative biological effectiveness of 225Ac compared to 177Lu during [225Ac]Ac-PSMA and [177Lu]Lu-PSMA radionuclide therapy
    Rumiantcev, M.
    Li, W.
    Lindner, S.
    Liubchenko, G.
    Resch, S.
    Bartenstein, P.
    Ziegler, S.
    Boening, G.
    Delker, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S363 - S363
  • [8] [177Lu]Lu-PSMA-617 Therapy in a Patient with Chronic Kidney Disease
    Mercolli, Lorenzo
    Mingels, Clemens
    Manzini, Giulia
    Cumming, Paul
    Zeimpekis, Konstantinos
    Xue, Song
    Alberts, Ian
    Uehlinger, Dominik
    Rominger, Axel
    Shi, Kuangyu
    Afshar-Oromieh, Ali
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (10) : 1570 - 1573
  • [9] AUTOMATED RADIOSYNTHESIS OF [177LU]LU-PSMA-617 ON THE IPHASE MULTISYN MODULE
    Wichmann, C.
    Ackermann, U.
    Poniger, Stan
    Young, K.
    Chan, G.
    Hofman, M.
    Lee, S. T.
    Sachinidis, J.
    Scott, A.
    [J]. INTERNAL MEDICINE JOURNAL, 2019, 49 : 31 - 32
  • [10] Automated radiosynthesis of [177Lu] Lu-PSMA-617 on the iPHASE MultiSyn module
    Wichmann, Christian
    Ackermann, Uwe
    Poniger, Stan
    Young, Kenneth
    Chan, James
    Hofman, Michael
    Sachinidis, John
    Scott, Andrew
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S329 - S329
12345